U.S.-based Iambic Therapeutics Pursues IPO, Focuses on HER2 Inhibitor IAM1363

Ministry of Trade, Industry and Energy and Ministry of Food and Drug Safety Sign Agreement on AI Transformation and Global Competitiveness in Biotech

Paragon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos

Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%

BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial

Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug

Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review